Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
CoVigilAI is a cutting-edge solution for monitoring medical literature that leverages artificial intelligence and sophisticated data analysis to identify and manage adverse drug reactions proactively, thereby safeguarding patient well-being and adhering to regulatory standards in real time. This platform simplifies the tracking of scientific and medical literature by sourcing information from major global databases like PubMed and Embase, offering customizable search parameters that enhance the pharmacovigilance literature review process. Additionally, it systematically reviews scientific articles and publications from various local journals, ensuring comprehensive global and localized literature oversight. Utilizing advanced algorithms, the system classifies Individual Case Safety Reports (ICSRs) into three categories: valid, potential, and invalid cases, while its automated key entity recognition capability adeptly identifies essential elements such as patients, medications, adverse reactions, and relevant medical events. This holistic approach not only streamlines the monitoring process but also significantly enhances the accuracy and efficiency of drug safety assessments.
Description
Validated by scientific research, our objective solutions for monitoring drowsiness ensure that you exceed all safety requirements. Elevate your driver monitoring system to the highest standards in the industry. You can either license our innovative solution or validate your existing system against two decades of reliable data. Our technology has received commercial validation from Vale, one of the largest mining companies globally. Experience real-time management and reporting through our instant cloud-based platform. This represents a groundbreaking future, where we identify key biomarkers associated with neurological conditions while driving. You can oversee your team remotely with ease, utilizing our cloud monitoring system to analyze and report findings. User-friendly and safety-focused, Optalert stands at the forefront of the medtech industry, specializing in drowsiness and impairment detection for over 20 years. Our technologies are grounded in the principle of blepharometry, a term introduced by our founder, Dr. Murray Johns, which refers to the precise measurement of eyelid movement using sophisticated sensors or cameras. The evolution of our technology continues to advance, promising even greater innovations in the field.
API Access
Has API
API Access
Has API
Integrations
Embase
PubMed
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
CoVigilAI
Country
India
Website
covigilai.in/
Vendor Details
Company Name
Optalert
Country
Australia
Website
www.optalert.com